Back

Delta troponin plus decision limits for the confirmation and exclusion of myocardial infarction using contemporary and high sensitive assays

15 October 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 4 - Biomarkers Biomarkers ACVC Premium Access Acute Cardiovascular Care 2016

About the speaker

Photo
Professor Paul Collinson

St George's Healthcare NHS Trust, London (United Kingdom of Great Britain & Northern Ireland)

9 More presentations in this session

Presentation thumbnail
Biomarkers of oxidative stress in patients with acute coronary syndrome
Doctor I. Kotlar (Skopje, MK)
Abstract Slides
Presentation thumbnail
Circulating endothelial-derived and mononuclear progenitor cells in post-myocardial infarction patients with metabolic syndrome and diabetes mellitus
Professor A. Berezin (Salzburg, AT)
Presentation thumbnail
CT-IGFBP-4 as a novel biomarker for long-term prognosis in patients with chest pain
Mr A. Garcia-Osuna (Barcelona, ES)
Abstract Slides
Presentation thumbnail
Evaluation of the clinical significance of high-sensitive cardiac troponin T versus contemporary troponin T assays in patients presenting with symptoms of acute coronary syndrome.
Doctor C. Pedersen (Aabenraa, DK)
Abstract Slides
Presentation thumbnail
High-sensitivity troponin I assay in patients with chest pain: correlation between significant coronary lesions with or without renal failure
Doctor A. Soeiro (Sao Paulo, BR)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 4 - Biomarkers

The Event

Event poster

Acute Cardiovascular Care 2016

15 October - 17 October 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources